Background
==========

*Helicobacter pylori*is a microaerophilic Gram-negative bacterium that chronically infects the gastric mucosa. It is recognised as a human pathogen associated not only with chronic gastritis \[[@B1]\], but also with peptic ulcer \[[@B2]\] and gastric cancer \[[@B3]\]. A commonly used molecular marker of *H. pylori*virulence is the *cagA*gene (cytotoxin-associated gene) \[[@B4]\], which is a part of the 40 kb Cag-Pathogenicity Island (*cag*-PAI) \[[@B5]\]. The CagA cytotoxin is directly injected into epithelial cells by a type IV secretion system, encoded by genes located in the *cag*-PAI \[[@B6]-[@B8]\]. In the host cell, CagA localises to the plasma membrane and undergoes phosphorylation on specific tyrosine residues within repeating penta amino acid Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs, present at the C-terminus of the protein \[[@B9],[@B10]\]. The C-terminal part, which contains the EPIYA motifs, has been shown to be highly variable, as opposed to the highly conserved N-terminal part \[[@B7],[@B11]-[@B13]\]. CagA EPIYA motifs are defined as EPIYA-A, -B, -C, and -D, according to the amino acid sequences that surround the EPIYA sequence \[[@B10],[@B13],[@B14]\]. CagA proteins nearly always possess EPIYA-A and EPIYA-B sites, followed by one to three repeats of EPIYA-C in Western-type \[[@B13]\] or EPIYA-D sites in East Asian-type of *H. pylori*clinical isolates \[[@B14]\]. It has been suggested that the variation in number of repeating EPIYA-C or -D motifs determines the biological activity of CagA in phosphorylation-dependent as well as phosphorylation-independent ways \[[@B10],[@B15]\]. It has also been shown that the number of CagA EPIYA-C motifs is an important factor for cancer risk among Western strains \[[@B16]\].

Numerous PCR assays have been reported for the identification of CagA EPIYA phosphorylation motifs \[[@B12]-[@B14],[@B17],[@B18]\]. To simplify the determination of the number and types of *cagA*EPIYA motifs present, Argent and co-workers \[[@B17]\] developed an elegant PCR-based approach for identification of individual EPIYA motifs, using a single forward primer and multiple reverse primers. In most studies, *cagA*EPIYA amplicons have been visualised by agarose gel electrophoresis and sequenced using various region specific primers \[[@B12]-[@B14],[@B17],[@B18]\].

In this study, we report on the analysis of amplicons derived from a single primer pair by automated capillary electrophoresis combined with direct sequencing using universal sequencing primers to assess variations in the *H. pylori cagA*EPIYA motifs. The technique also works in the presence of multiple *H. pylori*strains in the same biopsy specimen.

Methods
=======

Study subjects and tissue collection
------------------------------------

Eleven individual archival frozen *H. pylori*positive gastritis tissue samples were used in this study. Preparation of multiple displacement amplified DNA (MDA-DNA) derived from DNA isolations and the detection limit of *Helicobacter pylori*MDA-DNA have been described previously \[[@B19],[@B20]\].

PCR amplification
-----------------

The *CagA*gene EPIYA repeat regions were amplified using 10 pmol of each primer M13-CagA-EPIYA.SE (5\'-*TGT AAA ACG ACG GCC AGT*CCC TAG TCG GTA ATG GRT TRT CT-3\') and T7-CagA-EPIYA.AS (5\'-*TAA TAC GAC TCA CTA TAG GG*T GTG GCT GTT AGT AGC GTA ATT GTC-3\'), 2 μl of MDA-DNA, and 1× HotStarTaq Master mix (Qiagen, Hilden, Germany) in a final reaction volume of 25 μl. Amplification conditions were as follows: initial denaturation at 95°C for 15 min; 30 cycles of 95°C for 30 s; 55°C for 30 s; 72°C for 1 min; and final extension at 72°C for 10 min. Prior to sequencing, amplicons were analysed by automated capillary electrophoresis using a QIAxcel system and a QIAxcel DNA High Resolution kit (Qiagen, Hilden, Germany), showing amplicons of different sizes depending on the variation and number of repeats (Figure [1](#F1){ref-type="fig"}). Primers for *CagE*were designed from *H. pylori*strain 26695 \[GenBank:[AE000511](AE000511)\] (*CagE*-M13-sense primer 5\'-*TGT AAA ACG ACG GCC AGT*GGG GGA ATA GGT TGT TTG GT-3\' and *CagE*-antisense primer 5\'-GGA TCA CCC CAT CAT CTA AAA A-3\', yielding an amplicon of \~385 bp), whereas *cag*-PAI empty-site primers were from Akopyants and co-workers \[[@B6]\] (M13-sense 5\'-*TGT AAA ACG ACG GCC AGT*ACA TTT TGG CTA AAT AAA CRC TG-3\' and *cag*-PAI empty-site T7-antisense 5\'-*TAA TAC GAC TCA CTA TAG GG*T CAT GCG AGC GGC GAT GTG-3\', yielding an amplicon of \~380 bp if the *cag***-**PAI is lost. PCR amplifications were carried out as described above using the following amplification conditions: initial denaturation at 95°C for 15 min; 30 cycles of 95°C for 20 s; 55°C (*cagE*) or 50°C (*cag*-PAI empty-site) for 20 s; 72°C for 40 s; and final extension at 72°C for 10 min. Subsequently, amplicons were analysed by automated capillary electrophoresis as described above.

![**A) Schematic drawing of the CagA EPIYA motifs detected in our clinical samples and its approximate sizes in bp (including the M13- and T7-sequence tags**. B) Size distribution of the *cagA*EPIYA motif amplicons derived from MDA-DNA of eleven gastritis biopsy specimens (No. 6, 9, 12, 14, 18, 21, 22, 23, 25, 27, and 28). J99, 26695, and 43509 indicate the position of *cagA*EPIYA motif amplicons derived from *H. pylori*J99, 26695, and ATCC 43509^T^DNA, respectively. A virtual size reference marker is indicated in the left margin and a reference marker for the different EPIYA motif sizes is indicated in the right margin. C) Representative electropherograms revealing the presence of a single (*cagA*EPIYA-AB; No. 6) or two different (*cagA*EPIYA-AB and EPIYA-ABC; No. 27) *cagA*EPIYA motifs, indicating the presence of either one or two isogenic *H. pylori*strains in the same biopsy specimen. 15 and 3000 indicate the position of lower and upper size markers.](1756-0500-3-35-1){#F1}

DNA sequence analysis
---------------------

Amplicon sequencing was done with the specified universal primers, via a custom sequencing service (Eurofins MWG Operon, Ebersberg, Germany). The obtained DNA sequences corresponding to *cagA*EPIYA motif repeats, derived from the nine *cagA*positive isolates and three reference strains (*H. pylori*26695, J99, ATCC 43509^T^) were translated into amino acid sequences, aligned and compared with catalogued *H. pylori*26695 \[GenBank:[AE000511](AE000511), *H. pylori*J99 \[GenBank:[AE001439](AE001439)\], *H. pylori*P12 \[GeneBank:[CP001217](CP001217)\], *H. pylori*G27 \[GenBank:[CP001173](CP001173)\], and *H. pylori*Shi470 \[GeneBank:[CP001072](CP001072)\] sequences using the CLC DNA Workbench software \[[@B21]\]. Sequences were retrieved from the NCBI nucleotide database \[[@B22]\].

Results and discussion
======================

We successfully amplified the variable 3\'-region of the *cagA*gene in nine of eleven MDA-DNA extracts from *H. pylori*positive gastritis biopsy specimens using a single PCR amplification, followed by automated capillary electrophoresis and universal primer-tagged amplicon sequencing. Electrophoretic analysis of the eleven cases revealed the presence of a single band in seven cases, multiple bands in two cases, while two cases were PCR negative (Figure [1](#F1){ref-type="fig"}; table [1](#T1){ref-type="table"}). The amplicons ranged in size between \~600 and \~900 bp, indicating the presence of varying numbers of *cagA*EPIYA motifs in the different biopsies. Amplicons derived from *H. pylori*26695 and *H. pylori*J99 revealed bands of similar sizes, whereas *H. pylori*ATCC 43509^T^generated a larger amplicon of \~1000 bp (Figure [1](#F1){ref-type="fig"}).

###### 

*H. pylori*genotyping

  ------------------------------------------------------------------------------------------------------------
  Subject No.        Gastritis classification^a^   16S rDNA^b^type   *cag*-PAI\     CagA\         
                                                                     PCR analysis   EPIYA types   
  ------------------ ----------------------------- ----------------- -------------- ------------- ------------
                                                                     ES^c^          *cagE*        

  6                  P-2-na                        \"Strain A\"      \-             \+            AB

  9                  A-I-a                         J99               \-             \+            ABC

  12                 C-3-a                         26695             \-             \+            ABC + ABCC

  14                 A-I-a                         26695             \-             \+            ABC

  18                 P-I-na                        26695             \-             \+            ABC

  21                 P-I-na                        J99               \+             \-            \-

  22                 C-I-a                         J99               \-             \+            AB

  23                 P-2-na                        26695             \-             \+            ABC

  25                 P-2-na                        26695             \-             \+            ABC

  27                 A-I-a                         26695             \-             \+            ABC + AB

  28                 A-I-na                        26695/J99         \-             \-            \-

  reference strain   HP 26695                      \-                \+             ABC           

  reference strain   HP J99                        \-                \+             BC            

  reference strain   ATCC 43509^T^                 \-                \+             ABCCC         
  ------------------------------------------------------------------------------------------------------------

a\) Gastritis classification according to the revised Sydney system \[[@B24]\]. **A**: antrum predominant gastritis; **P**: pangastritis; **C**: corpus dominant gastritis; **I**: mild degree; **2**: moderate degree; **3**: severe degree; **a**: atrophy; **na**: no atrophy

b\) 16S rDNA variable V3 region motifs established by pyrosequencing analysis \[[@B19]\].

c\) ES: *cag*-PAI empty-site, + presence of a 380 bp amplicon, indicating loss of *cag*-PAI; - presence of *cag*-PAI \[[@B6]\].

To assess the presence or loss of *cag*-PAI, *cagE*and *cag*-PAI empty-site PCR assay was carried out. *CagE*was detected in nine of eleven cases corresponding to the results of *cagA*genotyping (Table [1](#T1){ref-type="table"}). Amplification of *cag*-PAI empty-site yielded a fragment of \~380 bp in biopsy specimen No. 21, revealing loss of *cag*-PAI. Thus, the result confirms the absence of *cagA*EPIYA motif and *cagE*amplicon in this biopsy specimen. *H. pylori*DNA derived from biopsy specimen No. 28, negative in *cagA*and *cagE*amplification, did not yield any empty-site amplicon of the expected size (Table [1](#T1){ref-type="table"}), suggesting the presence of a deviating *cag*-PAI.

To confirm the *cagA*EPIYA motif genotype results obtained by fragment length analysis, we sequenced the amplicons using universal M13- and T7-sequencing primers. In seven of the eleven cases, an AB or ABC (Western type) *cagA*EPIYA motif was present (Table [1](#T1){ref-type="table"}). In two additional cases, double *cagA*EPIYA motifs (ABC+ABCC or ABC+AB) were detected. Presumably, this indicates the presence of two individual strains in the same biopsy specimen (Table [1](#T1){ref-type="table"}). The analysis of *cagA*EPIYA motifs from mixed *H. pylori*strain infection was possible by a combination of capillary electrophoresis and sequencing. The presence of *cagA*EPIYA-A and EPIYA-B motifs could be determined from the sequencing chromatograms, but the region of the repeating C-motifs contained double peaks caused by amplicons of different sizes and nucleotide compositions. Instead, the high resolution capillary electrophoreses analysis enabled us to determine the number of EPIYA-C motifs by the size of the amplicons.

DNA sequencing of reference strains revealed the presence of a *cagA*EPIYA-ABC motif in *H. pylori*26695, a *cagA*EPIYA-BC motif in *H. pylori*J99, and a *cagA*EPIYA-ABCCC motif in *H. pylori*ATCC 43509^T^(Table [1](#T1){ref-type="table"}).

In previous reports, the 3\'-end of the *cagA*gene encoding the EPIYA repeats were analysed by single or multiplex PCR assays and visualisation of amplicons by agarose gel electrophoresis. In most studies, amplicons are sequenced using a battery of gene specific primers (often the PCR primers). DNA sequence analysis of cloned amplicons with universal sequence primers (such as M13 uni -21), targeting sequences flanking cloned inserts \[[@B14],[@B16],[@B17]\], has also been described. The present study describes a unique PCR assay that detects all of the *cagA*phosphorylation sites, including the Asian EPIYA-D type. Tagging of the PCR primers enables rapid sequencing for revealing individual differences in the samples. Moreover, many laboratory workers are also concerned about the use of ethidium-bromide stained agarose gels, which is a health-risk factor. In agreement with a previous study from our laboratory we show that the use of automated capillary electrophoresis, which is a rapid technique that also minimizes the health risk during electrophoresis, overcomes these obstacles \[[@B19]\].

Commonly, work identifying *cagA*genotypes as potential virulence factors has been performed on bacterial isolates cultured from gastric biopsy specimens. However, bacterial culture methods are often time-consuming. In this view, the present and a previous study have shown that direct PCR on MDA-DNA derived from biopsy DNA provides a reliable source for multiple molecular analyses \[[@B19]\]. Using random amplified polymorphic DNA (RAPD) fingerprint analysis, it was found that \~60% of the patients were infected by two or more different *H. pylori*strains \[[@B23]\]. Using the methodological approaches described herein, we were able to detect multiple DNA fragments, indicating that the method indeed is suitable for analyzing mixed *H. pylori*infection in two gastric biopsy specimens (Table [1](#T1){ref-type="table"}).

Due to the limited number of biopsies analysed here, we were not able to draw any conclusions regarding a possible correlation between the gastritis classification and *cagA*genotypes. However, the primary goal of the present study was not to perform a clinical study at large but rather to establish a new and simple methodological approach to assess variations in *H. pylori cagA*EPIYA motifs.

Altogether, the single PCR reaction with MDA-DNA as template, in combination with the automated capillary electrophoresis and direct sequencing of universal primer-tagged amplicons, offers a rapid means of genotyping *H. pylori*DNA isolated from biopsy specimens. Moreover, the technique described allowed for a rapid detection of mixed *H. pylori*strains present in the same biopsy specimen.
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